BR100 Increased By (0.98%)
BR30 Increased By (1.28%)
KSE100 Increased By (0.93%)
KSE30 Increased By (1.06%)
AGHA 6.46 Increased By ▲ 0.08 (1.25%)
BECO 4.35 No Change ▼ 0.00 (0%)
BML 62.30 Decreased By ▼ -0.25 (-0.4%)
BOP 31.43 Increased By ▲ 0.04 (0.13%)
CNERGY 11.87 Increased By ▲ 0.14 (1.19%)
CSIL 5.88 Decreased By ▼ -0.03 (-0.51%)
FCCL 62.30 Increased By ▲ 0.59 (0.96%)
FFL 14.95 Increased By ▲ 0.16 (1.08%)
FNEL 1.32 Increased By ▲ 0.08 (6.45%)
KEL 6.35 Increased By ▲ 0.03 (0.47%)
KOSM 5.88 Decreased By ▼ -0.02 (-0.34%)
LOTCHEM 24.93 Increased By ▲ 0.24 (0.97%)
MLCF 106.50 Increased By ▲ 2.57 (2.47%)
NBP 174.70 Increased By ▲ 1.38 (0.8%)
NCPL 52.30 Increased By ▲ 0.47 (0.91%)
NPL 54.75 Increased By ▲ 0.72 (1.33%)
OGDC 320.30 Increased By ▲ 4.43 (1.4%)
PACE 9.35 Increased By ▲ 0.09 (0.97%)
PAEL 35.94 Increased By ▲ 0.36 (1.01%)
PIBTL 13.90 Increased By ▲ 0.24 (1.76%)
PPL 229.85 Increased By ▲ 3.78 (1.67%)
PRL 81.80 Increased By ▲ 1.52 (1.89%)
PTC 47.10 Increased By ▲ 0.46 (0.99%)
SSGC 24.00 Increased By ▲ 0.18 (0.76%)
TBL 9.25 Increased By ▲ 0.01 (0.11%)
TELE 7.59 Increased By ▲ 0.04 (0.53%)
TPL 25.00 Increased By ▲ 0.46 (1.87%)
TPLP 13.09 Increased By ▲ 0.10 (0.77%)
TREET 26.05 Increased By ▲ 0.07 (0.27%)
TRG 53.90 Increased By ▲ 0.57 (1.07%)
World

German vaccine official: rare clots after AstraZeneca shots were 20 times higher

  • His comments came as the European Medicines Agency and Britain's medical regulator acknowledged a possible link between the AstraZeneca vaccine to very rare cases of unusual blood clots with low blood platelets, with most cases reported in women under 60 years of age within two weeks of vaccination.
Published Updated
By

BERLIN: Instances of rare clotting in people who got AstraZeneca's COVID-19 vaccine were 20 times higher than would be likely in the same time period among a specific age group, Christian Bogdan, a member of Germany's vaccine committee, said on Wednesday.

His comments came as the European Medicines Agency and Britain's medical regulator acknowledged a possible link between the AstraZeneca vaccine to very rare cases of unusual blood clots with low blood platelets, with most cases reported in women under 60 years of age within two weeks of vaccination.

Regulators said the benefits of the AstraZeneca shot still outweigh risks.

Comments

Comments are closed for this article.